|
HY-D1683-10mg
|
MedChemexpress LLC
|
NBD-PE [CAS 178119-00-1]
|
|
|
|
|
HY-D1683-5mg
|
MedChemexpress LLC
|
NBD-PE [CAS 178119-00-1]
|
|
|
|
|
HY-P3581-1mg
|
MedChemexpress LLC
|
PE 22-28 [CAS 1801959-12-5]
|
|
|
|
|
HY-P701293-20ug
|
MedChemexpress LLC
|
PE-labeled Glypican-3/GPC3, Human (HEK293, His)
|
|
|
|
|
HY-P701293-50ug
|
MedChemexpress LLC
|
PE-labeled Glypican-3/GPC3, Human (HEK293, His)
|
|
|
|
|
HY-14672-1mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-14672-10mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-14672-25mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-14672-5mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-14672-50mg
|
MedChemexpress LLC
|
Soblidotin [CAS 149606-27-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-D1816-300T
|
MedChemexpress LLC
|
Vari Fluor 555-Phalloidin
|
|
|
|
|
HY-D1816-50T
|
MedChemexpress LLC
|
Vari Fluor 555-Phalloidin
|
|
|
|
|
HY-144012-10mg
|
MedChemexpress LLC
|
16:0 PEG2000 PE [CAS 474922-84-4]
|
|
|
|
|
HY-144012-5mg
|
MedChemexpress LLC
|
16:0 PEG2000 PE [CAS 474922-84-4]
|
|
|
|
|
HY-P7539-10ug
|
MedChemexpress LLC
|
APT-1/LYPLA1, Human (His)
|
|
|
|
|
HY-P7539-50ug
|
MedChemexpress LLC
|
APT-1/LYPLA1, Human (His)
|
|
|
|
|
HY-B0304A-100mg
|
MedChemexpress LLC
|
Dapoxetine (hydrochloride) [CAS 129938-20-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0304A-50mg
|
MedChemexpress LLC
|
Dapoxetine (hydrochloride) [CAS 129938-20-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0304A-1mL
|
MedChemexpress LLC
|
Dapoxetine (hydrochloride) [CAS 129938-20-1] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W111226-100mg
|
MedChemexpress LLC
|
Fmoc-His(3-Me)-OH [CAS 252049-16-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-W111226-250mg
|
MedChemexpress LLC
|
Fmoc-His(3-Me)-OH [CAS 252049-16-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-W111226-50mg
|
MedChemexpress LLC
|
Fmoc-His(3-Me)-OH [CAS 252049-16-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-13682B-1mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13682B-10mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13682B-5mg
|
MedChemexpress LLC
|
MifaMu rtide (sodium) [CAS 90825-43-7]
|
|
COVID-19-immunoregulation
|
|
